Astra-Zeneca Case Study

Astra-Zeneca case study

Contents
Introduction................................................................................................................................3
Background of company............................................................................................................3
Main Body..................................................................................................................................3
Key business strategies of the company within 5 years.........................................................3
Resources and capabilities of Astra-Zeneca..........................................................................6
Implementation of sustainable approaches by Astra-Zeneca.................................................7
Conclusion..................................................................................................................................9
References................................................................................................................................10

Introduction
Often companies grow to a stage at which the entrepreneur himself can't handle it all.
This is a wonderful time to begin dreaming about a plan which will direct the company
towards achieving its goals, such as inspiring others to decide. They will also illustrate the
company to their clients, networks, mentors, consultants, accountants, borrowers and
customers with a well-developed approach to achieve your corporate goals (Cheng and et. al.,
2019). It is essential for measures such as funding. Focusing on the agenda of an organisation
is going to help managers discover the key to growth and set a course to achieve the
corporate objectives. It may also allow companies to develop new products or services. It will
make choices that clash, or end up in a weak financial and strategic situation, without a
consistent management plan. In this report Astra-Zeneca is being taken into consideration. It
is a pharmaceutical company which have to deal with various consequences of today’s
pandemic situation. In addition to it, this report will highlight various business strategies to
counter with competition and various sustainable approaches followed by the firm in given
operational marketplace (Fox and McLaughlin, 2018).
Background of company
Astra-Zeneca is a British-Swedish multinational pharmaceutical company. The
respective company is being headquartered in Cambridge, England. The company deals in
providing vaccines to including major area of disease such as oncology, cardiovascular,
infection and many such other related disease. In recent times the firm is giving its valuable
contribution in pandemic situation i.e. COVID. Company currently is working with Leif
Johansson as the current chairman and Pascal Soriot as the CEO of the business firm.
Respective company is well known in today’s times for its involvement in developing
Oxford-AstraZeneca COVID-19 vaccine. By analysing the aims and objectives of the given
company it can be evaluated that, managers of the firm are working towards deriving
maximum social benefits and completion of various social objectives of the firm on a priority
basis along with operational objectives of the corporate firm (Goetzel and et. al., 2019).
Main Body
Key business strategies of the company within 5 years
Market strategy may be understood as a path or series of decisions that help
entrepreneurs to achieve clear business goals. It is a master plan to protect the

competitiveness, operate, satisfy consumers and meet the desired goals of an organisation
through its management. It's just a master plan. It's the long-term sketch of the company's
desired logo, course and goal. It is an operation and organisational purpose scheme that is
carefully orchestrated and engineered. A corporate strategy is a series of competitive steps
that a company takes in order to recruit, succeed effectively, improve results and accomplish
organisational objectives. It explains how to do business for the desired purposes. In order to
find, analysis and utilise advantageous prospects and sensitive risks, to make the best use of
capabilities and strengths and to counterbalance vulnerability, the business plan provides a
comprehensive mechanism for top-level management. In respect with chosen firm, its
business strategy over 5 year time period are as follows:
Partnerships and Mergers: In the pharmaceutical industry every day partnerships and
outsourcing take place. A strong corporate growth approach for a pharmaceutical industry is
to seek and to update sustainable mergers. The European management centre, according to
estimates, is supposed to lead more than 50% of potential business development in world
markets to the mergers of drug firms. By merging capital, AstraZeneca use their capabilities
to boost market share and power. To understand the importance of a corporate approach such
as the integrated integration of working cultures and processes would cover aspects of post-
fusion management.
Technological based strategies: Investment in scientific advances is a lucrative
pharmaceutical company growth practise. The market facing concrete threats include trends
such as increased competitiveness, globalisation and shorter product-cycle periods.
Technological advances enable a pharmaceutical manufacturer, by bringing more customers
and vendors together, to address these problems and receive immediate reviews at a lower
cost. All of these strategies is to use e-details to inform an organisation on the Internet of
product details. Customers can arrange health of people to hear about goods or get their
questions answered in real time by an enterprise. A drug firm can also use a telephone
application to allow users to search on their telephones for the dangers and benefits of the
medication. A technology-based market growth approach promotes drug improvement
technologies or innovative drug manufacturing.
Operational marketing and sales: The development and viability of a pharmaceutical
industry depends upon an integrated marketing and distribution plan. A U.S. Bureau of
Statistics survey of October 2011 recorded a 37% increase from 2003 to 2009 in the U.S.